Abstract
This report details worldwide the incidence and prevalence by country/region
of vision disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and
retinal disease), and details the current and projected market for diagnostic
and therapeutic products in the management of these vision disorders,
including general vision diagnostics, diagnostics for glaucoma, corneal and
retinal disorders, and therapeutic options for these disorders including use
of pharmaceuticals, surgery and devices. The report details current products
and technologies in use and the status of development of novel products under
development. The report details the clinical and technology developments
underlying this huge and evolving worldwide market, with data on products in
development and on the market; market size and forecast; competitor market
shares; competitor profiles; and market opportunity. Separate size, growth
and competitor share data are presented for the U.S., individual western
European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and
other key international markets; Asia (India, Korea, Australia, Russia and
China), the Americas (Canada, Mexico, Brazil) and Middle East and Africa
categories. The report profiles a minimum of 100 companies, with equitable
inclusion or exclusion of specific companies based on consistent criteria.
The company profiles provide detailed information on 10-15 major competitors,
and brief profiles of companies with less sizeable current or potential
positions in the market and additional profiles of companies with noteworthy
novel or advanced research activities in the market.
The report establishes the market size for key international markets (as
indicated above) for major technology segments as a baseline for and
projecting growth in the market over a ten-year forecast. The report also
assesses and projects the composition of the market (shifts in share based on
technology) as technologies gain or lose relative market performance over this
period.
| 
View Cart
